3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
9
Neoplasms
4
Neoplasm Metastasis
4
Multiple Myeloma
4
Gastrointestinal Stromal Tumors
4
Thyroid Neoplasms
2
Pancreatic Neoplasms
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Kidney Neoplasms
2
Gastrointestinal Neoplasms
2
Carcinoma, Hepatocellular
2
Carcinoma
2
Adenoma, Islet Cell
2
Uveal Melanoma
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Urinary Bladder Neoplasms
1
Thymoma
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroendocrine Tumors
1
Neoplasms by Site
1
Metastatic Digestive System Neuroendocrine Tumor G1
1
Meningioma
1
Interventions
pembrolizumab
3
fludarabine
3
aldesleukin
3
Cyclophosphamide
3
cabozantinib
2
Specimen Handling
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Ipilimumab
2
CTLA-4 Antigen
2
olaparib
1
gallium 68 PSMA-11
1
enfortumab vedotin
1
darolutamide
1
Therapeutics
1
Radiosurgery
1
Radiation Dose Hypofractionation
1
Pluvicto
1
Mitomycin
1
Lutetium-177
1
Lutetium
1
Loperamide
1
Geriatric Assessment
1
Gemcitabine
1
Fulvestrant
1
Fluorouracil
1
Fecal Microbiota Transplantation
1
Exercise
1
Continuous Positive Airway Pressure
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Urogenital Neoplasms
×
Sunitinib
×
90 days
×
Clear all
No trials found.